RxDoctor Payments Data

Charity Priyadarshi

Family · Conroe, TXNPI 1578036000

Payments from drug & device makers

$8,292in general payments, 2019–2025

Across 223 payments — averaging $37.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Janssen Research & Development, LLC$1K
  • Biogen$1K
  • Merck$821
  • Amgen$510
  • Novartis$456
  • plus $3K from 29 others

What the payments were for

  • Travel & lodging$3,01236%
  • Food & beverage$5,18563%
  • Education$941%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,292 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.

See all family providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Enbrel SureclickEtanercept37$259,961
RinvoqUpadacitinib27$224,790
Humira PenAdalimumab23$196,292
TavneosAvacopan11$185,733
Cosentyx Sensoready PenSecukinumab21$169,996
OtezlaApremilast23$127,257
Humira(Cf) PenAdalimumab17$122,500
Orencia ClickjectAbatacept12$104,923
Actemra ActpenTocilizumab14$81,806
TymlosAbaloparatide12$33,241
SavellaMilnacipran Hcl12$13,371
Hydroxychloroquine Sulfate185$8,777
MethotrexateMethotrexate Sodium152$4,535
Leflunomide66$3,320
Cevimeline Hcl14$3,145

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenTavneos, Otezla$510$312,99034 claims
AbbVieRinvoq, Savella$395$238,16139 claims
Radius Health, Inc.Tymlos$73$33,24112 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 15,456 family providers in Texas.

Other family in Conroe

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →